| scholarly article | Q13442814 |
| P50 | author | Robin Murray | Q7352679 |
| Antonio Waldo Zuardi | Q60324489 | ||
| Mario R. Louza | Q63952006 | ||
| José Alexandre de Souza Crippa | Q66605755 | ||
| Maristela S Schaufelberger | Q114386359 | ||
| Wagner Farid Gattaz | Q20742758 | ||
| Geraldo Busatto Filho | Q58494073 | ||
| Ulysses S. Torres | Q52967426 | ||
| Fabio Luis Souza-Duran | Q56856272 | ||
| P2093 | author name string | Helio Elkis | |
| Claudia C Leite | |||
| Antonio Carlos Santos | |||
| Paulo C Sallet | |||
| Jaime Eduardo C Hallak | |||
| Claudio C Castro | |||
| Caroline Y O Kanegusuku | |||
| Débora P Bassitt | |||
| P2860 | cites work | The Relationship of Structural Alterations to Cognitive Deficits in Schizophrenia: A Voxel-Based Morphometry Study | Q59784347 |
| Schizophrenia as a progressive brain disease | Q60610023 | ||
| Neuroanatomical correlates of psychosis in temporal lobe epilepsy: voxel-based morphometry study | Q62601697 | ||
| Epidemiology of early-onset schizophrenia | Q72009122 | ||
| Gray matter volume differences and the effects of smoking on gray matter in schizophrenia | Q81341337 | ||
| A systematic review of the long-term outcome of early onset schizophrenia | Q21260322 | ||
| Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis | Q22241687 | ||
| The myth of schizophrenia as a progressive brain disease | Q24067152 | ||
| Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies | Q24626182 | ||
| The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia | Q24643935 | ||
| Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys | Q24654374 | ||
| A review of MRI findings in schizophrenia | Q24657354 | ||
| Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses | Q27000464 | ||
| A fast diffeomorphic image registration algorithm | Q28243996 | ||
| The positive and negative syndrome scale (PANSS) for schizophrenia | Q28301751 | ||
| Unified segmentation | Q29616050 | ||
| Implications of normal brain development for the pathogenesis of schizophrenia | Q29618740 | ||
| Adjusting for global effects in voxel-based morphometry: gray matter decline in normal aging | Q30444055 | ||
| Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry | Q30476040 | ||
| Reducing inter-subject anatomical variation: effect of normalization method on sensitivity of functional magnetic resonance imaging data analysis in auditory cortex and the superior temporal region | Q30484061 | ||
| Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? | Q30695945 | ||
| Lack of progression of brain abnormalities in first-episode psychosis: a longitudinal magnetic resonance imaging study | Q57403293 | ||
| Grey matter abnormalities in Brazilians with first-episode psychosis | Q57403320 | ||
| Finding the Elusive Psychiatric "Lesion" With 21st-Century Neuroanatomy: A Note of Caution | Q30990470 | ||
| Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia | Q30994462 | ||
| Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies | Q31023592 | ||
| The Alzheimer's disease neuroimaging initiative | Q31030939 | ||
| Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies | Q31043017 | ||
| A nonparametric method for automatic correction of intensity nonuniformity in MRI data | Q32061718 | ||
| Limbic structures and networks in children and adolescents with schizophrenia | Q33302997 | ||
| Interpreting scan data acquired from multiple scanners: a study with Alzheimer's disease | Q33306779 | ||
| Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings | Q33425487 | ||
| The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review. | Q33494667 | ||
| A systematic review of the effects of antipsychotic drugs on brain volume | Q33525203 | ||
| Neuroimaging predictors of transition to psychosis--a systematic review and meta-analysis. | Q33530424 | ||
| Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. | Q33775024 | ||
| Assessing age-related gray matter decline with voxel-based morphometry depends significantly on segmentation and normalization procedures | Q33791561 | ||
| Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. | Q33814201 | ||
| Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies | Q33860665 | ||
| The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis | Q33865677 | ||
| Meta-analysis of regional brain volumes in schizophrenia | Q33885349 | ||
| Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication | Q33921159 | ||
| The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys | Q33985626 | ||
| Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. | Q34351095 | ||
| Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis | Q34393431 | ||
| Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression | Q34415969 | ||
| The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies | Q34468314 | ||
| Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys | Q34576434 | ||
| Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance | Q34698353 | ||
| Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study | Q34871391 | ||
| Workshop on defining the significance of progressive brain change in schizophrenia: December 12, 2008 American College of Neuropsychopharmacology (ACNP) all-day satellite, Scottsdale, Arizona. The rapporteurs' report | Q34983518 | ||
| First-episode studies in schizophrenia: criteria and characterization | Q35423831 | ||
| Abnormalities in structural covariance of cortical gyrification in schizophrenia | Q35783530 | ||
| Patterns of Gray Matter Abnormalities in Schizophrenia Based on an International Mega-analysis | Q35950776 | ||
| Cumulative adversity and smaller gray matter volume in medial prefrontal, anterior cingulate, and insula regions | Q36081676 | ||
| Insular volume abnormalities associated with different transition probabilities to psychosis | Q36145094 | ||
| Longitudinal progression of frontal and temporal lobe changes in schizophrenia | Q36145602 | ||
| Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function | Q36157849 | ||
| Insular Gray Matter Volume and Objective Quality of Life in Schizophrenia | Q36257468 | ||
| Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies | Q36386404 | ||
| Imaging artifacts at 3.0T. | Q36587734 | ||
| Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings | Q36666237 | ||
| A large scale (N=400) investigation of gray matter differences in schizophrenia using optimized voxel-based morphometry | Q36825086 | ||
| Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. | Q36914354 | ||
| Heritability of multivariate gray matter measures in schizophrenia | Q36960391 | ||
| Multi-site voxel-based morphometry: methods and a feasibility demonstration with childhood absence epilepsy | Q37015847 | ||
| Voxel-based morphometric multisite collaborative study on schizophrenia. | Q37100383 | ||
| The role of the insula in schizophrenia | Q37787511 | ||
| Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity | Q39281477 | ||
| Incidence of first-contact psychosis in São Paulo, Brazil | Q39824255 | ||
| Neurodevelopmental schizophrenia: the rediscovery of dementia praecox | Q40598538 | ||
| How reliable are gray matter disruptions in specific reading disability across multiple countries and languages? Insights from a large-scale voxel-based morphometry study. | Q41565878 | ||
| Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity | Q41608731 | ||
| Resting-state brain activity in schizophrenia and major depression: a quantitative meta-analysis | Q41970913 | ||
| Validity of modulation and optimal settings for advanced voxel-based morphometry | Q43562326 | ||
| Is DARTEL-based voxel-based morphometry affected by width of smoothing kernel and group size? A study using simulated atrophy. | Q44187195 | ||
| Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease | Q45296229 | ||
| Intracranial volume estimated with commonly used methods could introduce bias in studies including brain volume measurements | Q45737996 | ||
| Changes in cortical thickness during the course of illness in schizophrenia. | Q45927962 | ||
| Reduced cortical folding in schizophrenia: an MRI morphometric study | Q48215568 | ||
| No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. | Q48244244 | ||
| Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? | Q48364681 | ||
| Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. | Q48373158 | ||
| Regional impact of field strength on voxel-based morphometry results | Q48422725 | ||
| Insight and regional brain volumes in schizophrenia | Q48425674 | ||
| Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry | Q48469886 | ||
| Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort | Q48510689 | ||
| What determines continuing grey matter changes in first-episode schizophrenia and affective psychosis? | Q48569172 | ||
| Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients | Q48704137 | ||
| Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder | Q48876360 | ||
| Regional gray matter volume deficits in adolescents with first-episode psychosis | Q48900458 | ||
| Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study | Q48968348 | ||
| Influence of magnetic field strength and image registration strategy on voxel-based morphometry in a study of Alzheimer's disease. | Q51210357 | ||
| Can voxel based morphometry, manual segmentation and automated segmentation equally detect hippocampal volume differences in acute depression? | Q51860451 | ||
| Cavum septum pellucidum and adhesio interthalamica in schizophrenia: an MRI study. | Q52028981 | ||
| Voxel-based morphometry of comorbid schizophrenia and learning disability: analyses in normalized and native spaces using parametric and nonparametric statistical methods. | Q52090092 | ||
| Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. | Q53080297 | ||
| Schizophrenia with auditory hallucinations: A voxel-based morphometry study | Q57233738 | ||
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 1-15 | |
| P577 | publication date | 2016-06-03 | |
| P1433 | published in | NeuroImage: Clinical | Q22907265 |
| P1476 | title | Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness | |
| P478 | volume | 12 |
| Q64079795 | Aberrant Brain Function in Active-Stage Ulcerative Colitis Patients: A Resting-State Functional MRI Study |
| Q59808651 | Aberrant Cerebral Activity in Early Postmenopausal Women: A Resting-State Functional Magnetic Resonance Imaging Study |
| Q38665865 | Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses. |
| Q64945067 | Brain function, structure and genomic data are linked but show different sensitivity to duration of illness and disease stage in schizophrenia. |
| Q55689951 | Cerebellar Structural Abnormalities Associated With Cognitive Function in Patients With First-Episode Psychosis. |
| Q41632096 | Changes in Resting-State Cerebral Activity in Patients with Hyperthyroidism: A Short-Term Follow-Up Functional MR Imaging Study |
| Q94600188 | Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients |
| Q55437545 | Classification of multi-site MR images in the presence of heterogeneity using multi-task learning☆. |
| Q38656732 | Cognitive correlates of neuroimaging abnormalities in the onset of schizophrenia: A case report |
| Q90303715 | Cognitive remediation in schizophrenia: the earlier the better? |
| Q94606278 | Common gray and white matter abnormalities in schizophrenia and bipolar disorder |
| Q54968552 | Gray Matter and White Matter Abnormalities in Temporal Lobe Epilepsy Patients with and without Hippocampal Sclerosis. |
| Q64085430 | Nerve Growth Factor Serum Levels Are Associated With Regional Gray Matter Volume Differences in Schizophrenia Patients |
| Q56876569 | Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression |
| Q64944506 | Progressive Grey Matter Volume Changes in Patients with Schizophrenia over 6 Weeks of Antipsychotic Treatment and Their Relationship to Clinical Improvement. |
| Q59135280 | Structural and functional brain abnormalities in drug-naive, first-episode, and chronic patients with schizophrenia: a multimodal MRI study |
| Q91130303 | The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal 18F-DOPA PET and voxel-based morphometry study |
| Q64108690 | Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates |
| Q64105494 | Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis |
| Q62725700 | Using Machine Learning and Structural Neuroimaging to Detect First Episode Psychosis: Reconsidering the Evidence |
Search more.